Namocatcat, Beteliano P.
HRN: 21-52-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/05/2022
07/11/2022
IV
600 Mg
Q6H
CAP-MR; T/C Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes